Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study By: Benzinga via Benzinga March 03, 2015 at 21:07 PM EST Orexigen Therapeutics, Inc. (NASDAQ: OREX) may have jumped the gun in reporting that its anti-obesity drug Contrave offers unexpected ... Read More >>